Qniumucin
| Internal ID | 095e864f-136d-4128-b3c8-518142103708 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S,3R)-3-[(2S,3R,4R,5R,6R)-3-acetamido-6-[[2-aminoethyl(hydroxy)phosphoryl]oxymethyl]-4,5-dihydroxyoxan-2-yl]oxy-2-[[(2S,3R)-3-[(2S,3R,4R,5R,6R)-3-acetamido-6-[[2-aminoethyl(hydroxy)phosphoryl]oxymethyl]-4,5-dihydroxyoxan-2-yl]oxy-2-aminobutanoyl]amino]butanoyl]amino]propanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]pentanedioic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C54H96N12O27P2/c1-22(2)36(48(78)62-30(52(82)83)13-14-34(69)70)64-49(79)37(23(3)4)63-46(76)31-12-11-17-66(31)51(81)25(6)59-45(75)24(5)58-50(80)38(27(8)91-54-40(61-29(10)68)44(74)42(72)33(93-54)21-89-95(86,87)19-16-56)65-47(77)35(57)26(7)90-53-39(60-28(9)67)43(73)41(71)32(92-53)20-88-94(84,85)18-15-55/h22-27,30-33,35-44,53-54,71-74H,11-21,55-57H2,1-10H3,(H,58,80)(H,59,75)(H,60,67)(H,61,68)(H,62,78)(H,63,76)(H,64,79)(H,65,77)(H,69,70)(H,82,83)(H,84,85)(H,86,87)/t24-,25-,26+,27+,30-,31-,32+,33+,35-,36-,37-,38-,39+,40+,41-,42-,43+,44+,53-,54-/m0/s1 |
| InChI Key | RYJBFSAVHUWBEW-AIBHYAFQSA-N |
| Popularity | 5 references in papers |
| Molecular Formula | C54H96N12O27P2 |
| Molecular Weight | 1407.40 g/mol |
| Exact Mass | 1406.59830983 g/mol |
| Topological Polar Surface Area (TPSA) | 617.00 Ų |
| XlogP | -16.20 |
| Atomic LogP (AlogP) | -7.45 |
| H-Bond Acceptor | 26 |
| H-Bond Donor | 19 |
| Rotatable Bonds | 37 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.9110 | 91.10% |
| Caco-2 | - | 0.8585 | 85.85% |
| Blood Brain Barrier | - | 0.8750 | 87.50% |
| Human oral bioavailability | - | 0.7143 | 71.43% |
| Subcellular localzation | Lysosomes | 0.5067 | 50.67% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8327 | 83.27% |
| OATP1B3 inhibitior | + | 0.9309 | 93.09% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9532 | 95.32% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8040 | 80.40% |
| CYP3A4 substrate | + | 0.7336 | 73.36% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8523 | 85.23% |
| CYP3A4 inhibition | - | 0.6834 | 68.34% |
| CYP2C9 inhibition | - | 0.8384 | 83.84% |
| CYP2C19 inhibition | - | 0.8104 | 81.04% |
| CYP2D6 inhibition | - | 0.8800 | 88.00% |
| CYP1A2 inhibition | - | 0.9008 | 90.08% |
| CYP2C8 inhibition | + | 0.6255 | 62.55% |
| CYP inhibitory promiscuity | - | 0.9539 | 95.39% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.5171 | 51.71% |
| Eye corrosion | - | 0.9809 | 98.09% |
| Eye irritation | - | 0.8956 | 89.56% |
| Skin irritation | - | 0.7649 | 76.49% |
| Skin corrosion | - | 0.9202 | 92.02% |
| Ames mutagenesis | - | 0.5800 | 58.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7029 | 70.29% |
| Micronuclear | + | 0.8800 | 88.00% |
| Hepatotoxicity | + | 0.5657 | 56.57% |
| skin sensitisation | - | 0.8558 | 85.58% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9500 | 95.00% |
| Nephrotoxicity | - | 0.5971 | 59.71% |
| Acute Oral Toxicity (c) | III | 0.5546 | 55.46% |
| Estrogen receptor binding | + | 0.5782 | 57.82% |
| Androgen receptor binding | + | 0.7338 | 73.38% |
| Thyroid receptor binding | + | 0.7044 | 70.44% |
| Glucocorticoid receptor binding | + | 0.7998 | 79.98% |
| Aromatase binding | + | 0.7767 | 77.67% |
| PPAR gamma | + | 0.7975 | 79.75% |
| Honey bee toxicity | - | 0.6967 | 69.67% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5900 | 59.00% |
| Fish aquatic toxicity | - | 0.4489 | 44.89% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.30% | 98.95% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.85% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.79% | 96.09% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 96.96% | 97.86% |
| CHEMBL3776 | Q14790 | Caspase-8 | 96.74% | 97.06% |
| CHEMBL4801 | P29466 | Caspase-1 | 96.72% | 96.85% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 96.08% | 95.17% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.01% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.01% | 100.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.70% | 93.10% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 94.82% | 97.25% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.74% | 91.11% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 93.39% | 95.93% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.32% | 97.09% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 92.80% | 91.19% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.75% | 90.71% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 92.62% | 98.24% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 92.57% | 99.17% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.23% | 99.17% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.17% | 96.47% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 92.09% | 93.33% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 91.45% | 96.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 90.86% | 94.33% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 90.67% | 99.18% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 90.48% | 92.50% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 90.36% | 97.50% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 90.26% | 100.00% |
| CHEMBL5957 | P21589 | 5'-nucleotidase | 90.17% | 97.78% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 89.82% | 96.67% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 89.52% | 94.45% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 88.67% | 98.94% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 88.27% | 95.38% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 88.25% | 90.17% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 87.25% | 96.03% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 87.09% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.00% | 95.89% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 87.00% | 94.01% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.77% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 86.72% | 97.14% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 86.65% | 98.10% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.65% | 91.03% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 86.54% | 93.18% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 85.91% | 92.38% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 85.81% | 95.00% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 85.69% | 99.77% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 85.66% | 95.52% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 85.63% | 92.86% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 85.39% | 93.00% |
| CHEMBL5028 | O14672 | ADAM10 | 84.75% | 97.50% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 84.00% | 89.50% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 83.49% | 95.89% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 83.42% | 85.14% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 83.32% | 97.64% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 83.19% | 96.77% |
| CHEMBL1075162 | Q13304 | Uracil nucleotide/cysteinyl leukotriene receptor | 82.87% | 80.33% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 82.78% | 88.42% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 82.71% | 97.29% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.65% | 95.50% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 82.64% | 96.67% |
| CHEMBL3468 | P55210 | Caspase-7 | 82.63% | 95.68% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 82.16% | 82.38% |
| CHEMBL3837 | P07711 | Cathepsin L | 81.47% | 96.61% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 81.13% | 85.00% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.81% | 98.75% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 80.60% | 93.04% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 80.54% | 96.38% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 80.20% | 80.71% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.06% | 94.66% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163105900 |
| LOTUS | LTS0184250 |
| wikiData | Q105247647 |